share_log

Telescope Innovations Files Game-Changing Provisional Patent to Purify Battery Materials

Telescope Innovations Files Game-Changing Provisional Patent to Purify Battery Materials

Telescope Innovations申請了改變遊戲規則的臨時專利,以淨化電池材料
newsfile ·  01/23 08:00

A novel refinement process generates battery-quality lithium carbonate in a single step

一種新的精製工藝只需一步即可生成電池質量的碳酸鋰

Vancouver, British Columbia--(Newsfile Corp. - January 23, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company") is a developer of advanced technologies and services for the global pharmaceutical and chemical industries. The Company focuses on process innovation, particularly for the production of medicinal compounds and battery materials. Telescope announces it has filed a provisional patent application (63/606,069) on a disruptive new technique to purify lithium carbonate, a critical mineral building block for lithium ion battery production and particularly for low-cost LFP battery chemistries. This is Telescope's second application related to processing battery raw materials, the first of which provides a low-temperature method for generating lithium sulfide.

不列顛哥倫比亞省溫哥華--(新聞檔案公司,2024年1月23日)——望遠鏡創新公司(CSE:TELI)(OTCQB:TELI)(OTCQB:TELIF)(”望遠鏡“或者”公司“)是爲全球製藥和化學行業提供先進技術和服務的開發商。該公司專注於工藝創新,特別是在藥用化合物和電池材料的生產方面。Telescope宣佈已就一種顛覆性的新技術提交了臨時專利申請(63/606,069),該技術旨在提純碳酸鋰,碳酸鋰是鋰離子電池生產,尤其是低成本LFP電池化學品的關鍵礦物基石。這是Telescope的第二項與電池原材料加工相關的應用,其中第一項爲生成硫化鋰提供了一種低溫方法。

The current provisional application describes a single-step process that produces battery-grade, >99.9% lithium carbonate from crude material of 20-95% purity (Figure 1). This technology can dramatically reduce the requirement for pre-processing of crude lithium brine feeds, which conventionally accounts for up to 80% of refinement costs.

當前的臨時申請描述了一種單步工藝,該工藝使用純度爲 20-95% 的原材料生產電池級 > 99.9% 的碳酸鋰(圖 1)。該技術可以顯著降低對粗鋰鹽水飼料的預處理需求,傳統上,粗鋰鹽水飼料佔精煉成本的80%。


Figure 1. Telescope's new process produces >99.9 % lithium carbonate (Li2CO3) from crude mixtures.


圖 1。 望遠鏡的新工藝可產生 >99.9% 的碳酸鋰(Li2CO3) 來自粗混合物。

To discover this new method, Telescope leveraged its rich expertise in pharmaceutical process development and crystallization. "The requirements for high purity, scalability, batch-to-batch consistency, and continuous operation are the same in the pharma and critical mineral industries," explained Jason Hein, CEO of Telescope. "It's cross-sector innovation. We brought the cutting-edge tools we use to advance pharmaceutical R&D, like our online analytical platforms, automation, and artificial intelligence tools, and applied them to the battery manufacturing space."

爲了發現這種新方法,Telescope利用了其在製藥工藝開發和結晶方面的豐富專業知識。 “製藥和關鍵礦產行業對高純度、可擴展性、批次間一致性和連續運行的要求是相同的,” 望遠鏡首席執行官傑森·海因解釋說。 “這是跨領域的創新。我們帶來了用於推進藥物研發的尖端工具,例如我們的在線分析平台、自動化和人工智能工具,並將其應用於電池製造領域。”

The Company aims to deploy its intellectual property through partnership and licensing models in the battery materials industry, leveraging its established and productive relationships with Standard Lithium Ltd., Natural Resources Canada, and Canada's Mining Innovation Commercialization Accelerator, among others. "As our network grows, we're strengthening existing partnerships and pursuing new opportunities to deploy and capitalize on our growing IP portfolio," added Hein.

該公司的目標是利用其與標準鋰業有限公司、加拿大自然資源部和加拿大礦業創新商業化加速器等建立的富有成效的關係,通過夥伴關係和許可模式在電池材料行業部署其知識產權。 “隨着我們網絡的發展,我們正在加強現有的合作伙伴關係,並尋求新的機會來部署和利用我們不斷增長的知識產權組合,” 海因補充說。

About Telescope

關於望遠鏡

Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Our aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.

Telescope是一家化學技術公司,爲製藥和化學行業開發可擴展的製造工藝和工具。該公司構建和部署新的支持技術,包括靈活的機器人平台和人工智能軟件,以提高實驗吞吐量、效率和數據質量。我們的目標是提供現代化學技術解決方案,以應對健康和可持續發展方面最嚴峻的挑戰。

On behalf of the Board,

代表董事會,

Telescope Innovations Corp.

望遠鏡創新公司

Jason Hein, Chief Executive Officer
E: jason@telescopeinn.com

傑森·海因,首席執行官
E: jason@telescopeinn.com

Forward-Looking Information

前瞻性信息

Forward-looking information is based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information.

前瞻性信息基於許多觀點、假設和估計,儘管截至本新聞稿發佈之日,公司認爲這些觀點、假設和估計是合理的,但受已知和未知的風險、不確定性、假設和其他因素的影響,這些因素可能導致實際結果、活動水平、業績或成就與此類前瞻性信息所表達或暗示的結果存在重大差異。

Forward-looking statements in this document include expectations surrounding the use and viability of Provisional Patent Application No. 63/606,069 for lithium carbonate purification, potential impacts of this technology on the refinement cost of lithium carbonate, the Company's ability to deploy its intellectual property through partnership and licensing models in the battery materials industry, and all other statements that are not statements of historical fact.

本文件中的前瞻性陳述包括對碳酸鋰提純的第63/606,069號臨時專利申請的使用和可行性的預期、該技術對碳酸鋰提煉成本的潛在影響、公司通過夥伴關係和許可模式在電池材料行業部署其知識產權的能力,以及所有其他非歷史事實陳述的陳述。

Examples of such assumptions, risks and uncertainties include, without limitation, assumptions, risks and uncertainties associated with the global COVID-19 pandemic; general economic conditions; adverse industry events; the Company's ability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the ability of the Company to implement its business strategies; competition; and other assumptions, risks and uncertainties.

此類假設、風險和不確定性的示例包括但不限於與全球 COVID-19 疫情相關的假設、風險和不確定性;總體經濟狀況;不利的行業事件;公司從內部和外部來源獲得足夠資本的能力,和/或無法以優惠條件獲得充足資本;公司實施業務戰略的能力;競爭;以及其他假設、風險和不確定性。

The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

本新聞稿中包含的前瞻性陳述自本新聞稿發佈之日起作出,除非法律要求,否則公司明確表示沒有義務更新或修改包含任何前瞻性信息或這些信息所依據的因素或假設的陳述,無論這些陳述是由於新信息、未來事件還是其他原因造成的。

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

CSE既未批准也未拒絕本新聞稿的內容。CSE及其市場監管機構(該術語在CSE的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論